APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 23 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,070 | -48.3% | 300,000 | 0.0% | 0.01% | -42.9% |
| Q2 2023 | $717,076 | +28.6% | 300,000 | 0.0% | 0.01% | +27.3% |
| Q1 2023 | $557,437 | +21.1% | 300,000 | 0.0% | 0.01% | +22.2% |
| Q4 2022 | $460,312 | -21.0% | 300,000 | 0.0% | 0.01% | -30.8% |
| Q3 2022 | $583,000 | +30.1% | 300,000 | 0.0% | 0.01% | +44.4% |
| Q2 2022 | $448,000 | -5.7% | 300,000 | 0.0% | 0.01% | +12.5% |
| Q1 2022 | $475,000 | +4.6% | 300,000 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $454,000 | +23.4% | 300,000 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $368,000 | -33.5% | 300,000 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $553,000 | +31.4% | 300,000 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $421,000 | -16.3% | 300,000 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $503,000 | +56.7% | 300,000 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $321,000 | – | 300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 28,825,000 | $35,498,000 | 0.69% |
| DeepCurrents Investment Group LLC | 15,079,000 | $18,525,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,996,000 | $41,869,000 | 0.36% |
| Weiss Asset Management LP | 9,000,000 | $10,980,000 | 0.28% |
| SSI INVESTMENT MANAGEMENT LLC | 3,418,000 | $4,192,000 | 0.25% |
| Baker Brothers Advisors | 46,754,000 | $57,262,000 | 0.25% |
| MACKAY SHIELDS LLC | 15,855,000 | $19,641,000 | 0.18% |
| Verition Fund Management LLC | 4,310,000 | $5,350,000 | 0.05% |
| WESTWOOD HOLDINGS GROUP INC | 1,000,000 | $1,236,000 | 0.01% |
| GIRARD PARTNERS LTD. | 66,081 | $162,000 | 0.01% |